STAT

Opinion: Access to medical cannabis: a new health care disparity

We need a new federal classification for medical marijuana, so insurance can cover it, and license more dispensaries to provide it. Both would help poor people in chronic pain access…
Containers of medicinal marijuana are seen on display at a dispensary in San Francisco.

The vast majority of Americans — nearly 95% of us — support the use of medical cannabis. Thirty-three states plus the District of Columbia have legalized it, and that number is likely to rise.

But like all swiftly embraced changes in public health, there can be unintended consequences of legalizing cannabis for medical uses. My colleagues and I are seeing this one: the rise of a new health care disparity, because it is harder

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks